Search Results - "Fernández‐Carballido, Cristina"
-
1
Female Sex, Age, and Unfavorable Response to Tumor Necrosis Factor Inhibitors in Patients With Axial Spondyloarthritis: Results of Statistical and Artificial Intelligence–Based Data Analyses of a National Multicenter Prospective Registry
Published in Arthritis care & research (2010) (01-01-2023)“…Objective Real‐world studies are needed to identify factors associated with response to biologic therapies in patients with axial spondyloarthritis (SpA). The…”
Get full text
Journal Article -
2
Psoriatic arthritis screening: A systematic literature review and experts' recommendations
Published in PloS one (15-03-2021)“…To analyze the performance of psoriatic arthritis (PsA) screening tools, examine their implementation in daily practice, and reach a consensus about the best…”
Get full text
Journal Article -
3
The paradigm of IL-23-independent production of IL-17F and IL-17A and their role in chronic inflammatory diseases
Published in Frontiers in immunology (04-08-2023)“…Interleukin-17 family (IL-17s) comprises six structurally related members (IL-17A to IL-17F); sequence homology is highest between IL-17A and IL-17F,…”
Get full text
Journal Article -
4
Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross‐Sectional Study
Published in Arthritis care & research (2010) (01-06-2020)“…Objective To evaluate the impact of comorbidities on physical function in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Methods This…”
Get full text
Journal Article -
5
Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis
Published in Frontiers in immunology (08-07-2022)“…IntroductionPatients with axial spondyloarthritis (axSpA) have a high disease burden mainly due to the rheumatic disease itself, and also exhibit accelerated…”
Get full text
Journal Article -
6
Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
Published in Arthritis research & therapy (13-04-2021)“…Vaspin is a novel anti-inflammatory adipokine associated with cardiovascular (CV) disease and inflammation in chronic inflammatory conditions different from…”
Get full text
Journal Article -
7
Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis
Published in Arthritis care & research (2010) (01-01-2017)“…Objective To describe health‐related quality of life (HRQOL) and physical function in patients with early axial spondyloarthritis (SpA) and to assess their…”
Get full text
Journal Article -
8
Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis
Published in Scientific reports (15-06-2020)“…Cardiovascular (CV) disease is the main cause of mortality in axial spondyloarthritis (axSpA). CV risk is enhanced by dysregulation of adipokines. Low omentin…”
Get full text
Journal Article -
9
Elevating the Standard of Care for Patients with Axial Spondyloarthritis: ‘Calls to Action’ from Rheumacensus, a Multistakeholder Pan-European Initiative
Published in Rheumatology and therapy. (01-06-2024)“…Introduction Several barriers to optimal care in axial spondyloarthritis (axSpA) exist, which is detrimental to patient outcomes. The Rheumacensus programme…”
Get full text
Journal Article -
10
Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
Published in Therapeutic advances in musculoskeletal disease (2021)“…Objective: To assess the efficacy and safety of tocilizumab (TCZ) in Caucasian patients with refractory Takayasu’s arteritis (TAK) in clinical practice…”
Get full text
Journal Article -
11
Sex-specific impact of inflammation on traditional cardiovascular risk factors and atherosclerosis in axial spondyloarthritis. A multicentre study of 913 patients
Published in Rheumatic & musculoskeletal diseases open (28-06-2024)“…IntroductionThe nature of the relationship between inflammation, cardiovascular (CV) risk factors and atherosclerosis in axial spondyloarthritis (axSpA)…”
Get full text
Journal Article -
12
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients
Published in Rheumatic & musculoskeletal diseases open (01-12-2022)“…ObjectivesTo evaluate effectiveness and safety of certolizumab pegol (CZP) in uveitis due to immune-mediated inflammatory diseases (IMID).MethodsMulticentre…”
Get full text
Journal Article -
13
Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis
Published in Therapeutic advances in musculoskeletal disease (2021)“…Background: Axial spondyloarthritis (axSpA) patients are known to have a higher prevalence of several comorbidities, including, among others, an increased risk…”
Get full text
Journal Article -
14
Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis
Published in Frontiers in medicine (21-12-2022)“…To evaluate gender differences in disease activity and health status (HS) in patients with radiographic axial spondyloarthritis (r-axSpA)/ankylosing…”
Get full text
Journal Article -
15
No radiographic sacroiliitis progression was observed in patients with early spondyloarthritis at 6 years: results of the Esperanza multicentric prospective cohort
Published in Rheumatic & musculoskeletal diseases open (01-09-2020)“…ObjectiveTo estimate the 6-year radiographic progression of sacroiliitis in patients with early spondyloarthritis (SpA).Patients and methodsSacroiliac joint…”
Get full text
Journal Article -
16
REDOSER project: optimising biological therapy dose for rheumatoid arthritis and spondyloarthritis patients
Published in Heliyon (01-11-2017)“…Reducing the dose of biological therapy (BT) when patients with immune-mediated arthritis achieve a sustained therapeutic goal may help to decrease costs for…”
Get full text
Journal Article -
17
Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study—results at 5 years of follow-up
Published in Rheumatology (Oxford, England) (18-06-2021)“…Abstract Objectives To determine cardiovascular (CV) mortality and incidence of the first CV event (CVE) in patients with chronic inflammatory rheumatic…”
Get full text
Journal Article -
18
Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients
Published in Seminars in arthritis and rheumatism (01-12-2022)“…To determine the potential impact of extra-articular manifestations (EAMs) on disease characteristics and cardiovascular (CV) risk in patients with axial…”
Get full text
Journal Article -
19
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients
Published in Seminars in arthritis and rheumatism (01-08-2022)“…•Identifying pro-atherogenic factors in rheumatic diseases can help prevent cardiovascular events.•Axial spondyloarthritis features associated with…”
Get full text
Journal Article -
20
Subclinical atherosclerotic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis. A multicenter study on 806 patients
Published in Seminars in arthritis and rheumatism (01-04-2021)“…To compare the atherosclerosis disease burden between ankylosing spondylitis (AS) and non-radiographic (nr) axial spondyloarthritis (axSpA) and establish a…”
Get full text
Journal Article